Celldex Therapeutics
IPOPublic · United States · $300.0M raised
- Business Model
- B2B
- Website
- celldex.com
- Total Funding
- $300.0M
- Last Round
- $300.0M Venture RoundMar 2024
- Rounds
- 1
- Type
- Public
About
Celldex Therapeutics is a biopharmaceutical company developing antibody-based combination immunotherapy treatments for cancer and other diseases.
Summary
Celldex Therapeutics is a Biotech company based in United States. It has raised $300.0M in total across 1 round, most recently a $300.0M Venture Round round in Mar 2024.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...